Meaghan Rose Smith is the first ever Executive Director of the Biosimilars Forum. She has spent her career in health care policy, with top roles in the U.S. Department of Health and Human Services, U.S. Senate, and U.S. House of Representatives. On the Senate Finance Committee, Meaghan worked along on the landmark Affordable Care Act which enacted the Biologics Price Competition and the Innovation Act (BPCIA), establishing the FDA’s pathway to review and approve biosimilars. Meaghan previously led the health care practice at SKDKnickerbocker, where she advised government leaders, CEOs, and started multi-party coalitions to achieve legislative and regulatory wins.